Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Matthews

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Palliative Medicine|October 25, 2006
Heart failure and palliative care services working in partnership: report of a new model of careAndrew Daley, Christine Matthews, Anne Williams
Facial Plastic Surgery Clinics of North America|November 19, 2023
Cleft Lip Repair and Primary and Intermediate Cleft RhinoplastiesChristine Matthews, Lisa Morris, Cassidy Woolie, et al.
Leukemia & Lymphoma|June 30, 2004
Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocolsChristine Matthews, Mark Catherwood, T C M 'Curly' Morris, et al.
Leukemia Research|May 23, 2006
V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosisChristine Matthews, Mark A Catherwood, T C M 'curly' Morris, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|February 16, 2006
An application of Rasch analysis to the measurement of communicative functioningPatrick J Doyle, William D Hula, Malcolm R McNeil, et al.
Leukemia & Lymphoma|April 10, 2008
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemiaLeeona Galligan, Mark A Catherwood, Christine Matthews, et al.
European Journal of Haematology|March 8, 2006
ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemiaMark A Catherwood, Christine Matthews, Roberta Niblock, et al.
Leukemia & Lymphoma|November 17, 2006
MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemiaChristine Matthews, Mark A Catherwood, Anne-Marie Larkin, et al.
European Journal of Haematology|July 22, 2006
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progressionChristine Matthews, Mark A Catherwood, T C M Morris, et al.
Annals of Internal Medicine|January 20, 2025
Stroke Rehabilitation: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice GuidelinesBlessen C Eapen, Johanna Tran, Jennifer Ballard-Hernandez, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Palliative Medicine|October 25, 2006
Heart failure and palliative care services working in partnership: report of a new model of careAndrew Daley, Christine Matthews, Anne Williams
Facial Plastic Surgery Clinics of North America|November 19, 2023
Cleft Lip Repair and Primary and Intermediate Cleft RhinoplastiesChristine Matthews, Lisa Morris, Cassidy Woolie, et al.
Leukemia & Lymphoma|June 30, 2004
Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocolsChristine Matthews, Mark Catherwood, T C M 'Curly' Morris, et al.
Leukemia Research|May 23, 2006
V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosisChristine Matthews, Mark A Catherwood, T C M 'curly' Morris, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|February 16, 2006
An application of Rasch analysis to the measurement of communicative functioningPatrick J Doyle, William D Hula, Malcolm R McNeil, et al.
Leukemia & Lymphoma|April 10, 2008
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemiaLeeona Galligan, Mark A Catherwood, Christine Matthews, et al.
European Journal of Haematology|March 8, 2006
ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemiaMark A Catherwood, Christine Matthews, Roberta Niblock, et al.
Leukemia & Lymphoma|November 17, 2006
MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemiaChristine Matthews, Mark A Catherwood, Anne-Marie Larkin, et al.
European Journal of Haematology|July 22, 2006
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progressionChristine Matthews, Mark A Catherwood, T C M Morris, et al.
Annals of Internal Medicine|January 20, 2025
Stroke Rehabilitation: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice GuidelinesBlessen C Eapen, Johanna Tran, Jennifer Ballard-Hernandez, et al.
Pageof 2